Cellular biology of somatostatin receptors

Neuropeptides

Volumn 35, Issue 1, 2001, Pages 1-23

  Csaba, Z ^a   Dournaud, P ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CORTACTIN; CORTACTIN BINDING PROTEIN 1; CORTISTATIN; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE; PROLINE RICH SYNAPSE ASSOCIATED PROTEIN; PROTEIN SHANK; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; SOMATOSTATIN RECEPTOR INTERACTING PROTEIN; UNCLASSIFIED DRUG;

DESENSITIZATION; HUMAN; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; MOLECULAR CLONING; NEUROMODULATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0035037495     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2001.0848     Document Type: Article

References (224)

1. Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes in transfected COS-7 cells
2. Somatostatin modulates voltage-gated K(+) and Ca(2+) currents in rod and cone photoreceptors of the salamander retina
3. Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells
4. Somatostatin is increased in the basal ganglia in Huntington disease
5. Beta-adrenergic and somatostatin receptors regulate Na-H exchange independent of cAMP
6. Gene regulation of somatostatin receptors in rats
7. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes
8. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease
9. Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration
10. Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238
11. Somatostatin receptors
12. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade
13. In vivo regulation of intraneuronal trafficking of G protein-coupled receptors for neurotransmitters
14. Proline-rich synapse-associated protein-1/cortactin binding protein 1 (ProSAPI/CortBP1) is a PDZ-domain protein highly enriched in the postsynaptic density
15. Proline-rich synapse-associated proteins ProSAPI and ProSAP2 interact with synaptic proteins of the SAPAP/GKAP family
16. Somatostatin inhibits excitatory transmission at rat hippocampal synapses via presynaptic receptors
17. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors
18. Somatostatin-induced regulation of SST(2A) receptor expression and cell surface availability in central neurons: Role of receptor internalization
19. sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1
20. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone
21. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2
22. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms
23. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins
24. Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells
25. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines
26. Somatostatin inhibits PDGF-stimulated Ras activation in human neuroblastoma cells
27. Both overlapping and distinct signaling pathways for somatostatin receptor subtypes SSTR1 and SSTR2 in pituitary cells
28. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells
29. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
30. Expression of somatostatin subtype 1 receptor in the rabbit retina
31. In vivo internalization of the somatostatin sst2A receptor in rat brain: Evidence for translocation of cell-surface receptors into the endosomal recycling pathway
32. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia
33. A cortical neuropeptide with neuronal depressant and sleep modulating properties
34. Cortistatin is expressed in a distinct subset of cortical interneurons
35. Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin
36. Regulation of ATP-sensitive K+ channels in insulinoma cells: Activation by somatostatin and protein kinase C and the role of cAMP
37. A specific G(o) heterotrimer couples somatostatin receptors to voltage-gated calcium channels in RINm5F cells
38. A tyrosine phosphatase is associated with the somatostatin receptor
39. S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ
40. G-protein-coupled receptor dimers in the lime light
41. Somatostatin-induced contraction of human isolated saphenous vein involves sst2 receptor-mediated activation of L-type calcium channels
42. Somatostatin messenger RNA-containing neurons in Alzheimer's disease: An in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex
43. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease
44. Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody
45. Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: Evidence for regulation of cell surface receptors by endogenous somatostatin
46. Somatostatin receptors
47. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: A primary role for tyrosine phosphatase SHP-1
48. Internalization and cellular processing of somatostatin in primary culture of rat anterior pituitary cells
49. Somatostatin stimulates BKCa channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid
50. Somatostatin in the central nervous system: Physiology and pathological modifications
51. Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy
52. Signal transduction of somatostatin receptors negatively controlling cell proliferation
53. The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells
54. Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors
55. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1)
56. Postnatal development of somatostatin 2A (sst2A) receptors expression in the rabbit retina
57. Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis
58. Somatostatin receptor subtype SSTR2 mediates the inhibition of highvoltage-activated calcium channels by somatostatin and its analogue SMS 201-995
59. Pituitary cell line GH3 expresses two somatostatin receptor subtypes that inhibit adenylyl cyclase: Functional expression of rat somatostatin receptor subtypes 1 and 2 in human embryonic kidney 293 cells
60. Modulation by somatostatin of glutamate sensitivity during developmerit of mouse hypothalamic neurons in vitro
61. Protein kinase C blocks somatostatin-induced modulation of calcium current in chick sympathetic neurons
62. Kinetic basis for the voltage-dependent inhibition of N-type calcium current by somatostatin and norepinephrine in chick sympathetic neurons
63. Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele
64. Coupling specificity between somatostatin receptor sst2A and G proteins: Isolation of the receptor-G protein complex with a receptor antibody
65. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation
66. Selective targeting of somatostatin receptor 3 to neuronal cilia
67. Immunohistochemical and cytochemical localization of the somatostatin receptor subtype sstl in the somatostatinergic parvocellular neuronal system of the rat hypothalamus
68. Immunohistochemical localization of the somatostatin receptor subtype 2 (sst2) in the central nervous system of the golden hamster (Mesocricetus auratus)
69. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina
70. Dimerization of cell surface receptors in signal transduction
71. The somatostatin receptors SSTR1 and SSTR2 are coupled to inhibition of adenylyl cyclase in Chinese hamster ovary cells via pertussis toxin-sensitive pathways
72. Outward current produced by somatostatin (SRIF) in rat anterior cingulate pyramidal cells in vitro
73. Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor
74. Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor
75. Internalization of the radioiodinated somatostatin analog [1251-Tyr3]octreotide by mouse and human pituitary tumor cells: Increase by unlabeled octreotide
76. Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2
77. Molecular pharmacology of somatostatin receptors
78. Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): Subtype selective internalization or upregulation
79. The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylyl cyclase and in mediating desensitization and internalization
80. Agonist-dependent up-regulation of human somatostatin receptor type 1 requires molecular signals in the cytoplasmic C-tail
81. Effect of G protein heterotrimer composition on coupling of neurotransmitter receptors to N-type Ca(2+) channel modulation in sympathetic neurons
82. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat
83. Expression of the somatostatin subtype 2A receptor in the rabbit retina
84. Somatostatin receptor subtype 2A expression in the rat retina
85. Human somatostatin receptor, SSTR2, is coupled to adenylyl cyclase in the presence of Gi alpha 1 protein
86. Fast inhibition of inwardly rectifying K+ channels by multiple neurotransmitter receptors in oligodendroglia
87. Molecular single-cell analysis identifies somatostatin type 1 (sst1) receptors to block inwardly rectifying K+ channels in rat brain oligodendrocytes
88. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain
89. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents
90. Different beta-subunits determine G-protein interaction with transmembrane receptors
91. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins
92. Endocytosis and recycling of G protein-coupled receptors
93. Somatostatin receptors in Neuro2A neuroblastoma cells: Ligand internalization
94. Fates of endocytosed somatostatin sst2 receptors and associated agonists
95. A novel system that reports the G-proteins linked to a given receptor: A study of type 3 somatostatin receptor
96. Somatostatin receptors
97. Gene structure and regulation of the somatostatin receptor type 2
98. Coupling of rat somatostatin receptor subtypes to a G-protein gated inwardly rectifying potassium channel (GIRK1)
99. Rat somatostatin receptor subtype 4 can be made sensitive to agonist-induced internalization by mutation of a single threonine (residue 331)
100. Immunoelectron microscopic analysis of the ligand-induced internalization of the somatostatin receptor subtype 2 in cultured human glioma cells
101. Multiple effector coupling of somatostatin receptor subtype SSTR1
102. Effector coupling of somatostatin receptor subtypes on human endocrine tumors
103. Arachidonate 5-lipoxygenase and its activating protein: Prominent hippocampal expression and role in somatostatin signaling
104. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: An electrophysiological and single cell RT-PCR study
105. Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors
106. Agonist binding to rat brain somatostatin receptors alters the interaction of the receptors with guanine nucleotide-binding regulatory proteins
107. Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2
108. Gi alpha 1 selectively couples somatostatin receptor subtype 3 to adenylyl cyclase: Identification of the functional domains of this alpha subunit necessary for mediating the inhibition by somatostatin of cAMP formation
109. Characterization of the Shank family of synaptic proteins. Multiple genes, alternative splicing, and differential expression in brain and development
110. Somatostatin inhibition of phosphoinositides turnover in isolated rat acinar pancreatic cells: Interaction with bombesin
111. G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells
112. Agonist-induced phosphorylation of somatostatin receptor subtype 1 (sst1): Relationship to desensitization and internalization
113. Molecular mechanisms of antiproliferative effect of somatostatin: Involvement of a tyrosine phosphatase
114. The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling
115. Identification and quantification of Gi-type GTP-binding proteins that copurify with a pituitary somatostatin receptor
116. Somatostatin potentiates the alpha 1-adrenergic activation of phospholipase C in striatal astrocytes through a mechanism involving arachidonic acid and glutamate
117. Somatostatin induces translocation of the beta-adrenergic receptor kinase and desensitizes somatostatin receptors in S49 lymphoma cells
118. Somatostatin-induced inhibition of neuronal Ca2+ current modulated by cGMP-dependent protein kinase
119. Somatostatin increases an inwardly rectifying potassium conductance in guinea-pig submucous plexus neurones
120. Internalization and subcellular distribution of radiolabeled somatostatin-28 in mouse anterior pituitary tumor cells
121. Somatostatin replacement therapy for Alzheimer dementia
122. Brain somatostatin receptor-G protein interaction G alpha C-terminal antibodies demonstrate coupling of the soluble receptor with Gi(1-3) but not with Go
123. Somatostatin receptor-mediated signaling in smooth muscle. Activation of phospholipase C-beta3 by Gbetagamma and inhibition of adenylyl cyclase by Galphail and Galphao
124. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin
125. Dopamine D2 receptor dimers and recepto-rblocking peptides
126. Differential internalization of somatostatin in COS-7 cells transfected with SSTI and SST2 receptor subtypes: A confocal microscopic study using novel fluorescent somatostatin derivatives
127. Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin-28
128. Characterization of cloned human somatostatin receptor SSTR5
129. sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kipl). Evidence for the role of SHP-1
130. G protein activation of a hormone-stimulated phosphatase in human tumor cells
131. Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affnity for somatostatin-28
132. All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase
133. Somatostatin and its receptor family
134. Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst3 receptor function by heterodimerization with sst2A
135. N-terminally extended somatostatin: The primary structure of somatostatin-28
136. Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells
137. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems
138. Somatostatin receptors
139. Characterization of cloned somatostatin receptors SSTR4 and SSTR5
140. Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin
141. Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: Coexpression with catalytically inactive SHP-2 blocks responsiveness
142. Somatostatin 1
143. Somatostatin 11
144. Prolonged somatostatin pretreatment desensitizes somatostatin's inhibition of receptor-mediated release of adrenocorticotropin hormone and sensitizes adenylate cyclase
145. Splice variant of the somatostatin receptor 2 subtype, somatostatin receptor 2B, couples to adenylyl cyclase
146. Molecular biology of somatostain receptors
147. Pharmacological properties of two cloned somatostatin receptors
148. Neurotransmitter-induced inhibition of exocytosis in insulin-secreting beta cells by activation of calcineurin
149. Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: Facts and artifacts
150. Characterization of the G protein coupling of a somatostatin receptor to the K+ ATP channel in insulinsecreting mammalian HIT and RIN cell lines
151. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy
152. Receptors for dopamine and somatostatin: Formation of heterooligomers with enhanced functional activity
153. Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers
154. Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells
155. Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization
156. Endocytosis of the rat somatostatin receptors: Subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs
157. On the mechanism of cytosolic phospholipase A2 activation in Clio cells carrying somatostatin receptor: Wortmannin-sensitive pathway to activate mitogen-activated protein kinase
158. Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20
159. Somatostatin receptors in the central nervous system
160. Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord
161. Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception
162. Localization of the somatostatin sst2(a) receptor in human cerebral cortex, hippocampus and cerebellum
163. Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant
164. Immunohistochemical localization of the somatostatin sst2(b) receptor splice variant in the rat central nervous system
165. Characterization of functional receptors for somatostatin in rat pituitary cells in culture
166. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain
167. Differential distribution of alternatively spliced somatostatin receptor 2 isoforms (sst2A and sst2B) in rat spinal cord
168. Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia
169. Agonist-independent internalization and activity of a C-terminally truncated somatostatin receptor subtype 2 (delta349)
170. Interaction of the somatostatin receptor subtype l with the human homolog of the Shk1 kinase-binding protein from yeast
171. Arachidonic acid metabolites as mediators of somatostatin-induced increase of neuronal M-current
172. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: Mediation by arachidonic acid and its metabolites
173. Somatostatin selectively couples to G(o) alpha in HIT-T15 cells
174. The MAPK signaling cascade
175. Distribution of somatostatin receptor subtypes in rat lumbar spinal cord examined with gold-labelled somatostatin and anti-receptor antibodies
176. Prolonged activation of extracellular signal-regulated kinase by a protein kinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors
177. Receptor isoforms mediate opposing proliferative effects through Gβγ-activated p38 or Akt pathways
178. First localisation of somatostatin sst(4) receptor protein in selected human brain areas: An immunohistochemical study
179. Immunohistochemical localization of the somatostatin sst(4) receptor in rat brain
180. The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gi alpha proteins
181. Substance P and somatostatin inhibit calcium channels in rat sympathetic neurons via different G protein pathways
182. Modulation of Ca2+ channels by PTX-sensitive G-proteins is blocked by N-ethylmaleimide in rat sympathetic neurons
183. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest
184. Platelet-activating factor and somatostatin activate mitogen-activated protein kinase (MAP kinase) and arachidonate release
185. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity
186. Somatostatin activates an inwardly rectifying K + conductance in freshly dispersed rat somatotrophs
187. Differential agonist activity of somatostatin and L-362855 at human recombinant sst4 receptors
188. The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidifcation
189. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat
190. Octapeptide somatostatin analog SMS 201-995 induces translocation of intracellular PTPIC to membranes in MCF-7 human breast adenocarcinoma cells
191. Somatostatin 2A receptor is expressed by enteric neurons and by interstitial cells of Cajal and enterochromaffin-like cells of the gastrointestinal tract
192. Parkinson's disease and dementia: Clinical and neurochemical correlations
193. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease - Effect of L-Dopa
194. The rat SSTR2 somatostatin receptor subtype is coupled to inhibition of cyclic AMP accumulation
195. Immunohistochemical distribution of the somatostatin receptor subtype 5 in the adult rat brain: Predominant expression in the basal forebrain
196. Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons
197. Intracellular dynamics of sst5 receptors in transfected COS-7 cells: Maintenance of cell surfuce receptors during ligand-induced endocytosis
198. Low levels of somatostatindike immunoreactivity in neocortex resected from presumed seizure loci in epileptic patients
199. Characterization of a membrane tyrosine phosphatase in AR42J cells: Regulation by somatostatin
200. Different G proteins mediate somatostatin-induced inward rectifier K+ currents in murine brain and endocrine cells
201. Gi3 mediates somatostatin-induced activation of an inwardly rectifying K+ current in human growth hormone-secreting adenoma cells
202. Gi alpha 1 selectively couples somatostatin receptors to adenylyl cyclase in pituitary-derived AtT-20 cells
203. Somatostatin acts by inhibiting the cyclic 3′, 5′-adenosine monophosphate (cAMP)/ protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency
204. Transfected human somatostatin receptor type 2, SSTR2, not only inhibits adenylate cyclase but also stimulates phospholipase C and Ca2 + mobilization
205. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins
206. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)
207. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization
208. Opposing mechanisms of regulation of a G-protein-coupled inward rectifier K+ channel in rat brain neurons
209. Modulation of high voltage-activated calcium channels by somatostatin in acutely isolated rat amygdaloid neurons
210. Processing of receptor-bound somatostatin: Internalization and degradation by pancreatic acini
211. Somatostatin-14 and somatostatin-28 induce opposite effects on potassium currents in rat neocortical neurons
212. Lack of cross-desensitization of somatostatin-14 and somatostatin-28 receptors coupled to potassium channels in rat neocortical neurons
213. Developmental changes in calcium current pharmacology and somatostatin inhibition in chick parasympathetic neurons
214. Somatostatin stimulates Ca(2+)- activated K+ channels through protein dephosphorylation
215. Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism
216. Homologous and heterologous desensitisation of somatostatin-induced increases in intracellular Ca2+ and inositol 1, 4, 5-trisphosphate in CHO-K1 cells expressing human recombinant somatostatin sst5 receptors
217. Somatostatin receptors, an expanding gene family: Cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase
218. Synamon, a novel neuronal protein interacting with synapse-associated protein 90/postsynaptic density-95-associated protein
219. Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase
220. Involvement of MAP kinase and c-fos signaling in the inhibition of cell growth by somatostatin
221. Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes
222. Calcineurin modulates G protein-mediated inhibition of N-type calcium channels in rat sympathetic neurons
223. Somatostatin receptor interacting protein defines a novel family of multidomain proteins present in human and rodent brain
224. Agonist-dependent inter-action of the rat somatostatin receptor subtype 2 with cortactin-binding protein 1